October 27, 2025, Swiss pharmaceutical giant Novartis revealed that it has acquired Avidity Biosciences, a leading U.S.-based biotechnology firm, in a deal valued at $12 billion. This strategic …
October 27, 2025, Swiss pharmaceutical giant Novartis revealed that it has acquired Avidity Biosciences, a leading U.S.-based biotechnology firm, in a deal valued at $12 billion. This strategic …
Stay ahead with TodayUS.com – your go-to source for the latest in business, sports, lifestyle, and technology. Get real-time updates, in-depth analysis, and breaking news on market trends, major sporting events, tech innovations, and lifestyle insights. Stay informed, stay empowered